John T Wilkins, MD
@jtwilkinsmd
Associate Professor of Cardiology and Preventive Medicine @NorthwesternMed @NMCardioVasc
Tweets are my own & RT do not = endorsements
ID: 1370132287560486912
11-03-2021 22:00:54
20 Tweet
230 Followers
253 Following
#Proteoform level characterization of human apolipoproteins will improve insight into the complex pathways through which proteins signify and mediate cardiometabolic health and disease. #cardiotwitter #prevention #cardiology Don Lloyd-Jones Neil Kelleher ahajournals.org/doi/10.1161/JA…
ApoB vs LDL-Cholesterol and Non-HDL-C as the Primary Measure of ApoB Lipoprotein-Related Risk ja.ma/3HkSObt via JAMA Cardiology part of JAMA Network
Excellent presentation by Simon Capewell in the Paul Dudley White session at #AHA21 Reminding us of the effectiveness hierarchy for public health- upstream efforts more impactful than downstream- “laws more effective than leaflets” Don Lloyd-Jones Sadiya Khan
How digital innovation can improve hypertension and LDL management. Great work from a great team Brigham and Women's Hospital congrats AJ Blood, MD, MS @jorgeplutzkymd Christopher Cannon, M.D. 🇺🇦 and the entire team!
Outstanding Presidential Address by a tireless advocate for improved #CVH, an incredible mentor, and an inspiration to all of us who are passionate to see reductions in #CVD. Also, he’s just great peeps! Congratulations to Don Lloyd-Jones! #AHA21 #cardiotwitter @american_heart
#COVID19 numbers are going up in Chicago, and we are preparing at NM Pulmonary and Thoracic Surgery. I talked with Jim Williams CBS Chicago. It's not too late to be fully #vaccinated by Christmas. chicago.cbslocal.com/2021/11/15/chi…
New findings by NUCATS Institute members John T Wilkins, MD and Charlesnika T Evans explore COVID-19 reinfection rates. The study also found that having had COVID-19 protects from future infection for only a moderate period of time — bit.ly/3HrEfTI
Incredibly excited to share our paper examining the association between diet quality and incident CV events stratified by BMI in a large pooled cohort! #medtwitter #CardioTwitter AJPC Thankful for all the mentorship! Don Lloyd-Jones John T Wilkins, MD Norrina Allen sciencedirect.com/science/articl…
Poster by John T Wilkins, MD et al. at #AHA22 impact of 22y cumulative apoB on ASCVD in CARDIA - similar risk from TRL-P and LDL-P - apoB > 0.80mg/dL per year a cut point of increased CV risk PROMINENT trial: ⬇️TRL-P offset by ⬆️LDL-P (apoB slightly ⬆️) - neutral result on outcomes.
Have you heard of ‘stiff left atrial syndrome’ from hereditary hypophosphatemia? Check out our awesome WeAreNUHeart fellow Johnny Hourmozdi’s poster on this challenging case of pulmonary HTN! Ruben Mylvaganam NM Cardiovascular NM Pulmonary and Thoracic Surgery #AHA22
Fantastic discussion of the #RESPECTEPA trial by Pam R. Taub, MD❤️💃🏻. #AHA22 AHA Science 👏👏👏 Still a role to consider EPA to address residual risk in secondary prevention patients.
Really interesting results from the #RESPECTEPA trial with commentary by Pam R. Taub, MD❤️💃🏻 So as we reconcile with REDUCE-IT & JELIS, the truth lies somewhere in between- well said! #EPAlevels UC San Diego Health Northwell Health Lenox Hill Hospital AHAMeetings Dr. Deepak L. Bhatt
Charlesnika T Evans Jackie Bannon, PhD, RN (she/her) Melanie Freedman Cerina Jae Young Lee @AmishaWalliaMD John T Wilkins, MD @Judymosk Really important work and so honored to work with this team on a paper led by a front line provider #hcw Northwestern MSS Havey Institute for Global Health